NO148776C - Aminderivater med antiperspirantvirkning samt antiperspirantmidler for topisk paafoering - Google Patents

Aminderivater med antiperspirantvirkning samt antiperspirantmidler for topisk paafoering

Info

Publication number
NO148776C
NO148776C NO784229A NO784229A NO148776C NO 148776 C NO148776 C NO 148776C NO 784229 A NO784229 A NO 784229A NO 784229 A NO784229 A NO 784229A NO 148776 C NO148776 C NO 148776C
Authority
NO
Norway
Prior art keywords
antiperpirant
aminery
derivatives
agents
effect
Prior art date
Application number
NO784229A
Other languages
English (en)
Norwegian (no)
Other versions
NO148776B (no
NO784229L (no
Inventor
Nicholas S Bodor
Original Assignee
Nyegaard & Co As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nyegaard & Co As filed Critical Nyegaard & Co As
Publication of NO784229L publication Critical patent/NO784229L/no
Publication of NO148776B publication Critical patent/NO148776B/no
Publication of NO148776C publication Critical patent/NO148776C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/90Benzo [c] furans; Hydrogenated benzo [c] furans with an oxygen atom in position 1 and a nitrogen atom in position 3, or vice versa
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO784229A 1977-12-16 1978-12-15 Aminderivater med antiperspirantvirkning samt antiperspirantmidler for topisk paafoering NO148776C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86121077A 1977-12-16 1977-12-16

Publications (3)

Publication Number Publication Date
NO784229L NO784229L (no) 1979-06-19
NO148776B NO148776B (no) 1983-09-05
NO148776C true NO148776C (no) 1983-12-14

Family

ID=25335183

Family Applications (1)

Application Number Title Priority Date Filing Date
NO784229A NO148776C (no) 1977-12-16 1978-12-15 Aminderivater med antiperspirantvirkning samt antiperspirantmidler for topisk paafoering

Country Status (15)

Country Link
JP (1) JPS5498711A (de)
AR (1) AR222478A1 (de)
AT (1) AT366380B (de)
AU (1) AU531835B2 (de)
CA (1) CA1102345A (de)
DE (1) DE2854308A1 (de)
DK (1) DK534178A (de)
ES (1) ES476048A1 (de)
FR (1) FR2422624A1 (de)
GB (1) GB2010270B (de)
IE (1) IE48012B1 (de)
IT (1) IT1101735B (de)
NL (1) NL7812257A (de)
NO (1) NO148776C (de)
SE (1) SE436027B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045055A1 (de) * 1980-11-29 1982-07-01 Celamerck Gmbh & Co Kg, 6507 Ingelheim Heterocyclische verbindungen
JPS5993075A (ja) * 1982-11-18 1984-05-29 Shionogi & Co Ltd 1−フタリジル−5−フルオロウラシル誘導体の製造法
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US5008111A (en) * 1984-10-11 1991-04-16 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
FR2703046B1 (fr) * 1993-03-26 1995-05-05 Poudres & Explosifs Ste Nale Procédé de préparation d'oxalates et d'halogénoglyoxalates alpha- monohalogénés et nouveaux oxalates et halogénoglyoxalates alpha-monohalogénés .
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US5962505A (en) * 1998-08-31 1999-10-05 Bobrove; Arthur M. Method for treating hot flashes in humans
US6433003B1 (en) 1999-04-23 2002-08-13 Arthur M. Bobrove Method for treating hyperhidrosis in mammals
AR044134A1 (es) * 2003-05-02 2005-08-24 Novartis Ag Derivados de quinuclidina, metodo de preparacion y composiciones farmaceuticas.
MX2007015255A (es) 2005-06-03 2008-02-22 Acrux Dds Pty Ltd Metodo y composicion para administracion transdermica de un farmaco.
US20100222393A1 (en) * 2005-12-30 2010-09-02 Naresh Kumar Muscarinic receptor antagonists
MX2010004789A (es) 2007-11-02 2010-07-05 Acrux Dds Pty Ltd Sistema de liberacion transdermica para hormonas y esteroides.
EP2903614B1 (de) * 2012-10-05 2021-09-29 Sphaera Pharma Pte. Ltd Neuartige verbindungen, deren synthese und deren verwendungen
DE102013013397A1 (de) 2013-08-13 2015-03-12 Epinamics Gmbh Aerosolspender für transdermal wirkende pharmazeutische Zusammensetzungen
CN110041264A (zh) * 2019-04-11 2019-07-23 贺州学院 一种金刚烷基咪唑类离子液体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL101555C (de) * 1955-03-19
BE798253A (nl) * 1973-04-16 1973-10-16 Bekaert Sa Nv Zitmeubel
US3998815A (en) * 1974-06-24 1976-12-21 Interx Research Corporation 1-hydrocarbonoyloxymethyl-3-carbamoyl or 3-carboethoxy-pyridinium salts

Also Published As

Publication number Publication date
NO148776B (no) 1983-09-05
DE2854308A1 (de) 1979-06-21
FR2422624A1 (fr) 1979-11-09
IE48012B1 (en) 1984-09-05
IE782499L (en) 1979-06-16
CA1102345A (en) 1981-06-02
ATA901478A (de) 1981-08-15
FR2422624B1 (de) 1983-10-14
GB2010270B (en) 1982-10-20
AR222478A1 (es) 1981-05-29
DK534178A (da) 1979-06-17
IT7830735A0 (it) 1978-12-12
NO784229L (no) 1979-06-19
SE436027B (sv) 1984-11-05
JPS5498711A (en) 1979-08-03
AU4264678A (en) 1979-06-21
GB2010270A (en) 1979-06-27
AU531835B2 (en) 1983-09-08
NL7812257A (nl) 1979-06-19
ES476048A1 (es) 1979-11-01
SE7812911L (sv) 1979-06-17
AT366380B (de) 1982-04-13
IT1101735B (it) 1985-10-07

Similar Documents

Publication Publication Date Title
FI781043A7 (fi) Styranordning foer en projektil av rakettyp samt en projektil foersedd med en dylik anordning
DK156151C (da) Svingnings- og accelerationsmaaler
SE400950B (sv) Forfarande vid justering av virkesstycken samt anordning for genomforande av forfarandet
NO148776C (no) Aminderivater med antiperspirantvirkning samt antiperspirantmidler for topisk paafoering
DK76279A (da) Substituerede pyridazonderivater med herbicid virkning
DK147378A (da) Imidazodiazepinderivater samt fremgangsmaade til fremstilling deraf
PL210042A1 (pl) Srodek owadobojczy i roztoczobojczy
NO783699L (no) Isotiazolderivater med soetningsvirkning
DK146026C (da) Beta-azolylketoner med fungicid virkning
DK318278A (da) Beta-lactamforbindelser samt deres femstilling og anvendelse
DK141178A (da) Flaske med patentlukke
IT1100070B (it) Cerniera perfezionata
FI781628A7 (fi) Foereningar av pregnanserien med en syrefunktion i 19-staellningen foerfaranden foer deras framstaellning samt farmaceutiska preparat innehaollande dessa foereningar
DK574678A (da) 2,3-dicyanopyrazinderivater med herbicid virkning samt deres fremstilling og anvendelse
SE7714859L (sv) Centrerings- och vridanordning
DK464076A (da) Thiazolidinderivater samt fremgangsmade til fremstilling deraf
DK242278A (da) 4-phenyl-8-amino-tetrahydroisoquinoliner samt anvendelse deraf
SE7801367L (sv) Kompositioner innehallande hudrerade segmentsampolymerer samt konstruktionstermoplaster
DK546578A (da) 2-oxo-hexahydroazepin-, -piperidin- og- pyrrolinderivater samt deres fremstilling og anvendelse
FI781711A7 (fi) Matarskiva i skivkvarn
IT1093317B (it) Voltapezzo per slebi e simili
DK167282A (da) Nitrosourinstofderivater med antitumorvirkning
DK557877A (da) Farvestofpraeparater samt deres anvendelse
IT1192305B (it) Mieti-trincia granoturco e simili
FI800892A7 (fi) Abonnentanslutningskoppling med jordningsknappindikation hoegohmig kopplingsbar matning samt anordning foer anropssignalgenerering